Literature DB >> 25881761

The association of Tyro3/Axl/Mer signaling with inflammatory response, disease activity in patients with primary Sjögren's syndrome.

Baodong Qin1, Jiaqi Wang2, Ning Ma1, Min Yang1, Haitao Fu1, Yan Liang1, Fenglou Huang1, Zaixing Yang3, Renqian Zhong4.   

Abstract

OBJECTIVES: Defects in Tyro3/Axl/Mer signaling may lead to impaired phagocytosis of apoptotic cells, eventually contributing to the development of autoimmune disease. The association of TAM signaling with several autoimmune disease has been investigated, but it remains unclear in primary Sjögren's syndrome. Therefore, the aim of this study was to evaluate the level of TAM signaling in primary Sjögren's syndrome with its clinical significance.
METHODS: Real-Time Polymerase Chain Reaction was used to determine the mRNA expression of Mer, Tyro-3, Axl, Gas6, and Protein S in Peripheral Blood Mononuclear Cell from 43 pSS and 46 control. The Enzyme-Linked Immunosorbent Assay method was used to test plasma levels of soluble TAM signaling from those individuals, and the relationship of their levels with clinical characteristic was evaluated.
RESULTS: The mRNA expression levels of Tyro-3, Axl were decreased in pSS patients. When considering the plasma level, increased levels of soluble Mer was observed with statistically significant difference. Soluble Mer levels were positively correlated with IgG levels (r=0.53, P<0.01), Erythrocyte Sedimentation Rate levels (r=0.44, P<0.01) and Sjögren's Syndrome Disease Activity Index (r=0.48, P<0.01). And the levels of soluble Mer in patients with the presence of SSA/SSB were higher than those without SSA/SSB.
CONCLUSIONS: The plasma levels of sMer were increased in pSS patients, which was associated with inflammatory response and disease activity.
Copyright © 2015 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Peripheral blood mononuclear cell; Plasma; Primary Sjögren's syndrome; TAM receptors

Mesh:

Substances:

Year:  2015        PMID: 25881761     DOI: 10.1016/j.jbspin.2015.01.008

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  12 in total

1.  MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.

Authors:  Bishuang Cai; Edward B Thorp; Amanda C Doran; Brian E Sansbury; Mat J A P Daemen; Bernhard Dorweiler; Matthew Spite; Gabrielle Fredman; Ira Tabas
Journal:  J Clin Invest       Date:  2017-01-09       Impact factor: 14.808

2.  Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction.

Authors:  L Xu; F Hu; H Zhu; X Liu; L Shi; Y Li; H Zhong; Y Su
Journal:  Clin Exp Immunol       Date:  2017-12-11       Impact factor: 4.330

Review 3.  Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.

Authors:  Gabrielle Fredman; Ira Tabas
Journal:  Am J Pathol       Date:  2017-06       Impact factor: 4.307

Review 4.  How Inflammation Blunts Innate Immunity in Aging.

Authors:  Emily L Goldberg; Albert C Shaw; Ruth R Montgomery
Journal:  Interdiscip Top Gerontol Geriatr       Date:  2020-04-09

Review 5.  The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Cancers (Basel)       Date:  2016-10-21       Impact factor: 6.639

6.  Age-related changes in expression and signaling of TAM receptor inflammatory regulators in monocytes.

Authors:  Xiaomei Wang; Anna Malawista; Feng Qian; Christine Ramsey; Heather G Allore; Ruth R Montgomery
Journal:  Oncotarget       Date:  2018-01-03

Review 7.  New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.

Authors:  Sara Pagani; Mattia Bellan; Daniele Mauro; Luigi Mario Castello; Gian Carlo Avanzi; Myles J Lewis; Pier Paolo Sainaghi; Costantino Pitzalis; Alessandra Nerviani
Journal:  Dis Markers       Date:  2020-01-19       Impact factor: 3.434

Review 8.  Efferocytosis in multisystem diseases (Review).

Authors:  Yifan Zhang; Yiru Wang; Jie Ding; Ping Liu
Journal:  Mol Med Rep       Date:  2021-11-15       Impact factor: 2.952

9.  Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet's disease.

Authors:  Jieying Qin; Lin Li; Donglei Zhang; Hongsong Yu; Handan Tan; Jun Zhang; Bolin Deng; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

10.  Selective Increment of Synovial Soluble TYRO3 Correlates with Disease Severity and Joint Inflammation in Patients with Rheumatoid Arthritis.

Authors:  Julia Vullings; Juliana P Vago; Claire E J Waterborg; Rogier M Thurlings; Marije I Koenders; Peter L E M van Lent; Peter M van der Kraan; Flavio A Amaral; Fons A J van de Loo
Journal:  J Immunol Res       Date:  2020-09-11       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.